Amgen Inc. (AMGN)
Amgen Inc. (AMGN) Company Bio
Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine. The company was founded in 1980 and is based in Thousand Oaks, California.
AMGN Stock Chart More Charts
AMGN Price/Volume Stats
| Current price | $188.34 |
| Prev. close | $186.68 |
| Day low | $185.99 |
| Day high | $189.10 |
| 50-day MA | $192.68 |
| 200-day MA | $192.19 |
| 52-week high | $210.19 |
| 52-week low | $163.31 |
| Volume | 3,314,600 |
| Avg. volume | 3,359,675 |
| Dividend yield | 2.83% |
| Market Cap | 120.01B |
AMGN Returns
| 1-mo | -4.57% |
| 3-mo | -2.26% |
| 6-mo | -3.19% |
| 1-year | 5.61% |
| 3-year | 39.12% |
| 5-year | 72.21% |
| YTD | -2.50% |
| 2018 | 15.23% |
| 2017 | 22.27% |
| 2016 | -7.56% |
| 2015 | 3.96% |
| 2014 | 42.33% |
AMGN Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...